Mirion Technologies, Inc. (MIR) Stock
NYSE · MIR
14.86
Fundamentals
Market cap
$3.79B
Price / Earnings ratio
159.6x
Price / Sales ratio
3.8x
Price / Book ratio
2.1x
Return on assets
1.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Implied Volatility Surging for Mirion Technologies Stock Options
NeutralMIRSeptember 25, 2026
Zacks Investment ResearchNeutral
Implied Volatility Surging for Mirion Technologies Stock Options
MIR

MarketBeat
Mirion Technologies Q2 Earnings Call Highlights
NeutralMIRJuly 30, 2026
MarketBeatNeutral
Mirion Technologies Q2 Earnings Call Highlights
MIR

Zacks Investment Research
Here's What Key Metrics Tell Us About Mirion Technologies (MIR) Q2 Earnings
NeutralMIRJuly 28, 2026
Zacks Investment ResearchNeutral
Here's What Key Metrics Tell Us About Mirion Technologies (MIR) Q2 Earnings
MIR

Zacks Investment Research
Mirion Technologies, Inc. (MIR) Q2 Earnings Beat Estimates
NeutralMIRJuly 28, 2026
Zacks Investment ResearchNeutral
Mirion Technologies, Inc. (MIR) Q2 Earnings Beat Estimates
MIR
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral1
Buy4
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
1B733M366M0
Debt & Balance Sheet
Total assets
Total liabilities
2025
4B3B1B0
Revenue to Profit
2025$925.4M
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$28.8M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Implied Volatility Surging for Mirion Technologies Stock Options
NeutralMIRSeptember 25, 2026
Zacks Investment ResearchNeutral
Implied Volatility Surging for Mirion Technologies Stock Options
MIR

MarketBeat
Mirion Technologies Q2 Earnings Call Highlights
NeutralMIRJuly 30, 2026
MarketBeatNeutral
Mirion Technologies Q2 Earnings Call Highlights
MIR

Zacks Investment Research
Here's What Key Metrics Tell Us About Mirion Technologies (MIR) Q2 Earnings
NeutralMIRJuly 28, 2026
Zacks Investment ResearchNeutral
Here's What Key Metrics Tell Us About Mirion Technologies (MIR) Q2 Earnings
MIR

Zacks Investment Research
Mirion Technologies, Inc. (MIR) Q2 Earnings Beat Estimates
NeutralMIRJuly 28, 2026
Zacks Investment ResearchNeutral
Mirion Technologies, Inc. (MIR) Q2 Earnings Beat Estimates
MIR

Business Wire
Mirion Announces Second Quarter 2026 Financial Results
NeutralMIRJuly 28, 2026
Business WireNeutral
Mirion Announces Second Quarter 2026 Financial Results
MIR

Zacks Investment Research
Is the Options Market Predicting a Spike in Mirion Technologies Stock?
NeutralMIRJuly 27, 2026
Zacks Investment ResearchNeutral
Is the Options Market Predicting a Spike in Mirion Technologies Stock?
MIR

Zacks Investment Research
Earnings Preview: Mirion Technologies, Inc. (MIR) Q2 Earnings Expected to Decline
NeutralMIRJuly 21, 2026
Zacks Investment ResearchNeutral
Earnings Preview: Mirion Technologies, Inc. (MIR) Q2 Earnings Expected to Decline
MIR

Business Wire
Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2026
NeutralMIRJuly 15, 2026
Business WireNeutral
Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2026
MIR

Zacks Investment Research
Mirion Technologies (MIR) Moves 5.4% Higher: Will This Strength Last?
NeutralMIRJune 19, 2026
Zacks Investment ResearchNeutral
Mirion Technologies (MIR) Moves 5.4% Higher: Will This Strength Last?
MIR

Zacks Investment Research
Watch 3 AI-Powered Nuclear Energy OEMs Amid Double-Digit Price Upside
NeutralMIRJune 3, 2026
Zacks Investment ResearchNeutral
Watch 3 AI-Powered Nuclear Energy OEMs Amid Double-Digit Price Upside
MIR
About Mirion Technologies, Inc.
No description available.
SectorIndustrials
IndustrySpecialty Industrial Machinery
Employees3,200
CEOMr. Thomas D. Logan
IPO DateAug 20, 2020
HeadquartersAtlanta, GA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Thomas D. Logan | Founder, Medical Group President, CEO & Chairman | 1961 |
| Mr. Brian Schopfer | CFO & Medical Group President | 1985 |
| Ms. Emmanuelle Lee J.D. | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary | — |
| Ms. Alison Ulrich | Chief Human Resources Officer | — |
| Mr. Loic Eloy | Group President of Nuclear & Safety Technologies | 1977 |
| Mr. Christopher Moore CPA | Chief Accounting Officer | 1972 |
| Mr. James Francis Charles Cocks | Chief Technology Officer | — |
| Mr. Marc Rubel | Chief Information Officer | — |
| Mr. Eric Linn | Vice President of Investor Relations | — |
| Ms. Erin Schesny | CMO & Senior VP of Government Affairs | — |
Fundamentals
Valuation
Market cap$3.79B
Price-to-sales ratio3.81
Price-to-book value2.14
Price-earnings ratio159.60
Return on Equity1.00%
Return on Sales7.00%
Return on Assets1.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$0.11
Income Statement
Average volume3,744,897
EBITDA$209.20M
1 year high (52w)$30.28
1 year low (52w)$14.11
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
5 Wall Street Analyst Ratings
BUY
80% Buy
20% Hold
0% Sell
Target price
$24.20
Est return
55.13%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.7 | -0.7 | -0.7 | |||||||||
| 2022 | -21.5 | +0.0 | -5.8 | +2.2 | +1.5 | -26.7 | +19.9 | +5.4 | +3.7 | +5.6 | -16.8 | +3.6 |
| 2023 | +19.4 | +12.7 | -6.2 | -3.9 | -4.0 | +5.9 | -9.3 | +13.3 | -12.6 | -7.2 | +32.1 | +15.3 |
| 2024 | -7.3 | +0.3 | +14.2 | -2.6 | +6.5 | +3.6 | -0.7 | +5.2 | +10.1 | +35.3 | +15.2 | +6.1 |
| 2025 | -6.4 | -0.4 | -3.4 | +10.0 | +21.3 | +11.7 | +8.9 | +3.2 | +12.9 | +27.1 | -11.5 | -6.9 |
| 2026 | +4.2 | -13.3 | -16.6 | +5.8 | -6.9 | +0.7 | -16.4 | -3.9 | +0.5 |



